-
1
-
-
48649094682
-
Histopathological assessment of prostate cancer bone osteoblastic metastases
-
Roudier MP, Morrissey C, True LD, Higano CS, Vessella RL, Ott SM. Histopathological assessment of prostate cancer bone osteoblastic metastases. J Urol 2008;180:1154-1160.
-
(2008)
J Urol
, vol.180
, pp. 1154-1160
-
-
Roudier, M.P.1
Morrissey, C.2
True, L.D.3
Higano, C.S.4
Vessella, R.L.5
Ott, S.M.6
-
2
-
-
24744439747
-
Prostate cancer cells promote osteoblastic bone metastases through Wnts
-
Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 2005;65:7554-7560.
-
(2005)
Cancer Res
, vol.65
, pp. 7554-7560
-
-
Hall, C.L.1
Bafico, A.2
Dai, J.3
Aaronson, S.A.4
Keller, E.T.5
-
3
-
-
0027052350
-
Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia
-
Bentley H, Hamdy FC, Hart KA, Seid JM, Williams JL, Johnstone D, Russell RG. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 1992;66:1159-1163.
-
(1992)
Br J Cancer
, vol.66
, pp. 1159-1163
-
-
Bentley, H.1
Hamdy, F.C.2
Hart, K.A.3
Seid, J.M.4
Williams, J.L.5
Johnstone, D.6
Russell, R.G.7
-
4
-
-
10744225879
-
Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein
-
Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nor J, McCauley LK, Taichman RS, Keller ET. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Cancer Res 2004;64:994-999.
-
(2004)
Cancer Res
, vol.64
, pp. 994-999
-
-
Dai, J.1
Kitagawa, Y.2
Zhang, J.3
Yao, Z.4
Mizokami, A.5
Cheng, S.6
Nor, J.7
McCauley, L.K.8
Taichman, R.S.9
Keller, E.T.10
-
5
-
-
37749040562
-
Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF
-
Fujita K, Janz S. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 2007;6:71.
-
(2007)
Mol Cancer
, vol.6
, pp. 71
-
-
Fujita, K.1
Janz, S.2
-
6
-
-
0024404268
-
-
Lowik CW, van der Bloys H, Hoekman K, Bijvoet OL, Aarden LA, Papapoulos SE. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 1989;162:1546-1552.
-
Lowik CW, van der PG, Bloys H, Hoekman K, Bijvoet OL, Aarden LA, Papapoulos SE. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 1989;162:1546-1552.
-
-
-
-
7
-
-
34248545487
-
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption
-
LuY, Cai Z, Xiao G, Keller ET, MizokamiA, Yao Z,RoodmanGD, Zhang J. Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res 2007;67:3646-3653.
-
(2007)
Cancer Res
, vol.67
, pp. 3646-3653
-
-
Lu, Y.1
Cai, Z.2
Xiao, G.3
Keller, E.T.4
Mizokami, A.5
Yao, Z.6
Roodman, G.D.7
Zhang, J.8
-
8
-
-
0032540319
-
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
-
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-176.
-
(1998)
Cell
, vol.93
, pp. 165-176
-
-
Lacey, D.L.1
Timms, E.2
Tan, H.L.3
Kelley, M.J.4
Dunstan, C.R.5
Burgess, T.6
Elliott, R.7
Colombero, A.8
Elliott, G.9
Scully, S.10
Hsu, H.11
Sullivan, J.12
Hawkins, N.13
Davy, E.14
Capparelli, C.15
Eli, A.16
Qian, Y.X.17
Kaufman, S.18
Sarosi, I.19
Shalhoub, V.20
Senaldi, G.21
Guo, J.22
Delaney, J.23
Boyle, W.J.24
more..
-
9
-
-
0037195141
-
The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification
-
Van WL, Odgren PR, MacKay CA, D'Angelo M, Safadi FF, Popoff SN, Van HW, Marks SC Jr. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc Natl Acad Sci USA 2002;99:14303-14308.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 14303-14308
-
-
Van, W.L.1
Odgren, P.R.2
MacKay, C.A.3
D'Angelo, M.4
Safadi, F.F.5
Popoff, S.N.6
Van, H.W.7
Marks Jr, S.C.8
-
10
-
-
0142147981
-
Characterization of C4-2 prostate cancer bone metastases and their response to castration
-
Pfitzenmaier J, Quinn JE, Odman AM, Zhang J, Keller ET, Vessella RL, Corey E. Characterization of C4-2 prostate cancer bone metastases and their response to castration. J Bone Miner Res 2003;18:1882-1888.
-
(2003)
J Bone Miner Res
, vol.18
, pp. 1882-1888
-
-
Pfitzenmaier, J.1
Quinn, J.E.2
Odman, A.M.3
Zhang, J.4
Keller, E.T.5
Vessella, R.L.6
Corey, E.7
-
11
-
-
32044447160
-
Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment
-
Brubaker KD, Brown LG, Vessella RL, Corey E. Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment. BMCCancer 2006;6:15.
-
(2006)
BMCCancer
, vol.6
, pp. 15
-
-
Brubaker, K.D.1
Brown, L.G.2
Vessella, R.L.3
Corey, E.4
-
12
-
-
16444368652
-
Osteoprotegerin in prostate cancer bone metastasis
-
Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL. Osteoprotegerin in prostate cancer bone metastasis. Cancer Res 2005;65:1710-1718.
-
(2005)
Cancer Res
, vol.65
, pp. 1710-1718
-
-
Corey, E.1
Brown, L.G.2
Kiefer, J.A.3
Quinn, J.E.4
Pitts, T.E.5
Blair, J.M.6
Vessella, R.L.7
-
13
-
-
44449108773
-
Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases
-
Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang YC, Corey E, Lange PH, Higano CS, Vessella RL. Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin Exp Metastasis 2008;25:377-388.
-
(2008)
Clin Exp Metastasis
, vol.25
, pp. 377-388
-
-
Morrissey, C.1
True, L.D.2
Roudier, M.P.3
Coleman, I.M.4
Hawley, S.5
Nelson, P.S.6
Coleman, R.7
Wang, Y.C.8
Corey, E.9
Lange, P.H.10
Higano, C.S.11
Vessella, R.L.12
-
14
-
-
0036604237
-
Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells
-
Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL. Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells. Prostate 2002;52:20-33.
-
(2002)
Prostate
, vol.52
, pp. 20-33
-
-
Corey, E.1
Quinn, J.E.2
Bladou, F.3
Brown, L.G.4
Roudier, M.P.5
Brown, J.M.6
Buhler, K.R.7
Vessella, R.L.8
-
15
-
-
28244481510
-
Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity
-
Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res 2005;65: 10921-10929.
-
(2005)
Cancer Res
, vol.65
, pp. 10921-10929
-
-
Kitagawa, Y.1
Dai, J.2
Zhang, J.3
Keller, J.M.4
Nor, J.5
Yao, Z.6
Keller, E.T.7
-
16
-
-
34547657084
-
Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists
-
Ye L, Lewis-Russell JM, Kynaston H, Jiang WG. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. J Urol 2007;178:1086-1091.
-
(2007)
J Urol
, vol.178
, pp. 1086-1091
-
-
Ye, L.1
Lewis-Russell, J.M.2
Kynaston, H.3
Jiang, W.G.4
-
17
-
-
0036133374
-
Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells
-
Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17:101-110.
-
(2002)
J Bone Miner Res
, vol.17
, pp. 101-110
-
-
Xiao, G.1
Gopalakrishnan, R.2
Jiang, D.3
Reith, E.4
Benson, M.D.5
Franceschi, R.T.6
-
18
-
-
0031834165
-
Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients
-
Akimoto S, Okumura A, Fuse H. Relationship between serum levels of interleukin-6, tumor necrosis factor-alpha and bone turnover markers in prostate cancer patients. Endocr J 1998;45: 183-189.
-
(1998)
Endocr J
, vol.45
, pp. 183-189
-
-
Akimoto, S.1
Okumura, A.2
Fuse, H.3
-
19
-
-
0035667565
-
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
-
Shariat SF, Andrews B, Kattan MW, Kim J, Wheeler TM, Slawin KM. Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology 2001;58:1008-1015.
-
(2001)
Urology
, vol.58
, pp. 1008-1015
-
-
Shariat, S.F.1
Andrews, B.2
Kattan, M.W.3
Kim, J.4
Wheeler, T.M.5
Slawin, K.M.6
-
20
-
-
0037053394
-
Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts
-
Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 2002;277:16879-16887.
-
(2002)
J Biol Chem
, vol.277
, pp. 16879-16887
-
-
Vermes, C.1
Jacobs, J.J.2
Zhang, J.3
Firneisz, G.4
Roebuck, K.A.5
Glant, T.T.6
-
21
-
-
0028266906
-
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
-
Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994;13:1189-1196.
-
(1994)
EMBO J
, vol.13
, pp. 1189-1196
-
-
Poli, V.1
Balena, R.2
Fattori, E.3
Markatos, A.4
Yamamoto, M.5
Tanaka, H.6
Ciliberto, G.7
Rodan, G.A.8
Costantini, F.9
-
22
-
-
0028224940
-
Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators
-
Zhu JF, Valente AJ, Lorenzo JA, Carnes D, Graves DT. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J Bone Miner Res 1994;9:1123-1130.
-
(1994)
J Bone Miner Res
, vol.9
, pp. 1123-1130
-
-
Zhu, J.F.1
Valente, A.J.2
Lorenzo, J.A.3
Carnes, D.4
Graves, D.T.5
-
23
-
-
0037105542
-
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae
-
Palmqvist P, Persson E, Conaway HH, Lerner UH. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 2002;169:3353-3362.
-
(2002)
J Immunol
, vol.169
, pp. 3353-3362
-
-
Palmqvist, P.1
Persson, E.2
Conaway, H.H.3
Lerner, U.H.4
-
24
-
-
13344250490
-
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
-
Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996;11:88-95.
-
(1996)
J Bone Miner Res
, vol.11
, pp. 88-95
-
-
Kotake, S.1
Sato, K.2
Kim, K.J.3
Takahashi, N.4
Udagawa, N.5
Nakamura, I.6
Yamaguchi, A.7
Kishimoto, T.8
Suda, T.9
Kashiwazaki, S.10
-
25
-
-
0025630163
-
Molecular cloning and expression of an IL-6 signal transducer, gp130
-
Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990;63:1149-1157.
-
(1990)
Cell
, vol.63
, pp. 1149-1157
-
-
Hibi, M.1
Murakami, M.2
Saito, M.3
Hirano, T.4
Taga, T.5
Kishimoto, T.6
|